Changmao Biochemical Engineering Company Limited (00954.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4Sep 9Sep 14

Key dataSep 14, 2026

OpenHKD 0.22

From 52W high−39.17%

Volume0.00

Market capHKD 115.98M

P/E (TTM)—

P/S (TTM)0.2x

Div yield—

Key dataSep 14, 2026

Open

HKD 0.22

From 52W high

−39.17%

Volume

0.00

Market cap

HKD 115.98M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

41.2x

P/E (TTM)

—

RSI (14)

13.8

MomentumView details →

1D Return

+0.46%

YTD Return

−23.16%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

41.2x

EV/Sales

1.0x

P/S (TTM)

0.2x

P/B (TTM)

0.2x

ProfitabilityView details →

Gross Margin

5.13%

Net Margin

−11.99%

EBITDA Margin

2.47%

ROE (TTM)

−12.92%

ROA (TTM)

−5.66%

Asset Turnover

0.46x

GrowthView details →

Revenue YoY

−4.77%

EPS YoY

+2.17%

FCF YoY

+110.63%

Revenue CAGR 3Y

−8.63%

EPS CAGR 3Y

+0.00%

EBITDA YoY

+177.68%

MomentumView details →

1D Return

+0.46%

YTD Return

−23.16%

1Y Return

−30.48%

RSI (14)

13.8

vs 50D SMA

−12.57%

vs 200D SMA

−26.04%

Capital & dividendView details →

Debt/Equity

1.04x

Current Ratio

0.50x

Quick Ratio

0.29x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.14B

Net Income (TTM)

−135.01M

Op. CF (TTM)

−13.35M

Latest newsMore news →

Changmao Biochemical Engineering announced its interim results for the six months ended June 2026, with revenue of RMB 290 million, up 6.3% year-on-year, and a narrowed net loss of RMB 4.932 million compared to a loss of RMB 25.79 million in the same period last year.33d ago

Similar companies

Wai Chun Bio-Technology Limited00660.HK FutureFuel Corp.FF Ko Yo Chemical (Group) Limited00827.HK Zhejiang Chang'an Renheng Technology Co., Ltd.08139.HK AdvanSix Inc.ASIX ASP Isotopes Inc. Common StockASPI Find similar companies →

Latest newsMore news →

Changmao Biochemical Engineering announced its interim results for the six months ended June 2026, with revenue of RMB 290 million, up 6.3% year-on-year, and a narrowed net loss of RMB 4.932 million compared to a loss of RMB 25.79 million in the same period last year.33d ago